Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.52 |
| ▸ | SLC1A5 | Q15758 | 1/20 | 0.43 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.43 |
| ▸ | ALPI | P09923 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | XIAP | P98170 | 1/20 | 0.42 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.42 |
| ▸ | IL1RN | P18510 | 2/20 | 0.41 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.41 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7029223 | 0.85 | IDO1 (0.56) | IDO1SLC1A5GRIK1ALPIPKM | |
| SCHEMBL13047077 | 0.82 | TSHR (0.50) | SMN1; SMN2TSHR | |
| SCHEMBL31149440 | 0.79 | SMN1; SMN2 (0.51) | SMN1; SMN2TSHR | |
| SCHEMBL7030449 | 0.78 | CA12 (0.48) | SMN1; SMN2 | |
| SCHEMBL14435224 | 0.78 | IDO1 (0.58) | IDO1SLC1A5GRIK1ALPIPKM | |
| SCHEMBL6559718 | 0.78 | ALDH1A1 (0.51) | SMN1; SMN2TSHR | |
| SCHEMBL27556300 | 0.78 | ALDH1A1 (0.51) | SMN1; SMN2TSHR | |
| SCHEMBL5186550 | 0.76 | ALDH1A1 (0.50) | SMN1; SMN2TSHR | |
| SCHEMBL1370980 | 0.76 | IDO1 (0.57) | IDO1SLC1A5ALPIPKMPTGS1 | |
| SCHEMBL1370981 | 0.76 | IDO1 (0.57) | IDO1SLC1A5ALPIPKMPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6569411-B2 | Deodoring, microbiocides, marking odors | THE GILLETTE COMPANY | 2003-05-27 | — | — | US | disclosed |
| US-20030018055-A1 | Serine carbonates | FRATER GEORGE (CH) | 2003-01-23 | — | — | US | disclosed |
| EP-1053223-A1 | SERINE CARBONATES | Givaudan SA (CH) | 2000-11-22 | — | — | EP | disclosed |
| WO-2000034232-A1 | SERINE CARBONATES | GIVAUDAN SA (CH) | 2000-06-15 | — | — | WO | disclosed |
| EP-1008587-A1 | Serine carbonates | Givaudan Roure (International) S.A. (CH) | 2000-06-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030018055-A1 | Serine carbonates | SRR, ME1, TASP1 | IDO1 1943/4885SLC1A5 1853/4885GRIK1 1937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.